Evidence map›Paper›PMID 33493737›Full record

ReviewClinical imaging2021

Systemic and CNS manifestations of inherited cerebrovascular malformations.

Blaine L Hart, Marc C Mabray, Leslie Morrison, Kevin J Whitehead, Helen Kim

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Clinical imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01764529 (Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformations), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01764529 completednot on this map

Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformations

Typeobservational_patient_registrySponsorUniversity of California, San FranciscoRan2010 to 2025Enrolled789ConditionsCavernous Angioma, Familial, Cerebral Cavernous Malformations, Cerebral Cavernous Hemangioma
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. [Cavernous hemangioma of the cauda equina: A case report].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Blaine L HartDepartment of Radiology, MSC10 5530, 1 University of New Mexico, Albuquerque, NM 87131, USA. Electronic address: bhart@salud.unm.edu.
Marc C MabrayDepartment of Radiology, MSC10 5530, 1 University of New Mexico, Albuquerque, NM 87131, USA. Electronic address: mamabray@salud.unm.edu.
Leslie MorrisonDepartment of Neurology, MSC10 5620, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA. Electronic address: lmorrison@salud.unm.edu.
Kevin J WhiteheadDivision of Cardiovascular Medicine and the Program in Molecular Medicine, University of Utah, 50 North Medical Drive, Salt Lake City, UT 84132, USA; George E. Wahlen Salt Lake City VA Medical Center, 500 Foothill Boulevard, Salt Lake City, UT 84148, USA. Electronic address: Kevin.Whitehead@hsc.utah.edu.
Helen KimCenter for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94143, USA. Electronic address: helen.kim2@ucsf.edu.
University of New Mexico · USUniversity of California, San Francisco · USUniversity of Utah · US

Funding

VCRC Administration UnitU54NS065705 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FAUGHNAN, MARIE E · 2009 to 2023
$20.8M
NINDS NIH HHS U54 NS065705
6 · The paper itself

Abstract

Cerebrovascular malformations occur in both sporadic and inherited patterns. This paper reviews imaging and clinical features of cerebrovascular malformations with a genetic basis. Genetic diseases such as familial cerebral cavernous malformations and hereditary hemorrhagic telangiectasia often have manifestations in bone, skin, eyes, and visceral organs, which should be recognized. Genetic and molecular mechanisms underlying the inherited disorders are becoming better understood, and treatments are likely to follow. An interaction between the intestinal microbiome and formation of cerebral cavernous malformations has emerged, with possible treatment implications. Two-hit mechanisms are involved in these disorders, and additional triggering mechanisms are part of the development of malformations. Hereditary hemorrhagic telangiectasia encompasses a variety of vascular malformations, with widely varying risks, and a more recently recognized association with cortical malformations. Somatic mutations are implicated in the genesis of some sporadic malformations, which means that discoveries related to inherited disorders may aid treatment of sporadic cases. This paper summarizes the current state of knowledge of these conditions, salient features regarding mechanisms of development, and treatment prospects.

Indexed as

Hemangioma, Cavernous, Central Nervous SystemTelangiectasia, Hereditary HemorrhagicCerebral ArteriesDiagnostic ImagingHumansSkinArteriovenous malformationCapillary malformation-arteriovenous malformationCerebral cavernous malformationCerebrovascular malformationsNeurocutaneous syndrome

Identifiers

PMID33493737
PMCPMC8169535
OpenAlexW3125920783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.